Evidence map›Paper›PMID 32073548›Full record

ArticleSexually transmitted diseases2020

First Case of High-Level Azithromycin-Resistant Neisseria gonorrhoeae in North Carolina.

Elizabeth L Palavecino, Abdullah Kilic, Matthew W Schmerer, Oana Dobre-Buonya, Cindy Toler, Candice J McNeil

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Sexually transmitted diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Local emergence and global evolution ofAntimicrobial agents and chemotherapy · 2024
    Article
  2. Review
  3. Sustained Transmission of Neisseria gonorrhoeae with High-Level Resistance to Azithromycin, in Indianapolis, Indiana, 2017-2018.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Elizabeth L PalavecinoFrom the Department of Pathology, Wake Forest School of Medicine and Wake Forest Baptist Health, Winston-Salem, NC.
Abdullah KilicFrom the Department of Pathology, Wake Forest School of Medicine and Wake Forest Baptist Health, Winston-Salem, NC.
Matthew W SchmererDivision of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
Oana Dobre-Buonya
Cindy TolerGuilford County Health Department, Greensboro, NC.
Candice J McNeil
Atrium Health Wake Forest Baptist · USGuilford County Schools · USCenters for Disease Control and Prevention · USWake Forest University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

We report on the first high-level azithromycin-resistant Neisseria gonorrhoeae isolate (minimum inhibitory concentration, ≥256 μg/mL) in North Carolina isolated from a pharyngeal swab of a 33-year-old HIV-negative man who has sex with men. In addition, the isolate was found to be susceptible to cefixime, ceftriaxone, and penicillin and resistant to tetracycline. By whole-genome sequencing, the strain was assigned as MLST ST9363, NG-MAST ST5035, and a novel NG-STAR sequence type, ST1993.

Indexed as

AdultAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxoneDrug Resistance, BacterialGonorrheaHIV SeronegativityHomosexuality, MaleHumansMaleMicrobial Sensitivity TestsMultilocus Sequence TypingNeisseria gonorrhoeaeNorth CarolinaPenicillinsAnti-Bacterial AgentsAzithromycinCefiximeCeftriaxonePenicillinsTetracycline

Identifiers

PMID32073548
PMCPMC10186591
OpenAlexW3008017230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.